Target intelligence / Profile preview

Neutral amino acid transporter A (ASCT1) (ASCT1)

Target
ASCT1
Molecular classification
Transporter, Solute carrier family 1, Amino acid exchanger
01

Overview

Neutral amino acid transporter A (ASCT1), encoded by the SLC1A4 gene, is a sodium-dependent amino acid exchanger primarily expressed in astrocytes and other glial cells within the central nervous system (UniProt P43007). It facilitates the obligatory exchange of small neutral amino acids, including L-serine, L-alanine, L-cysteine, and L-threonine, playing a pivotal role in the "serine shuttle" that maintains brain amino acid homeostasis (Kaplan et al., 2018). ASCT1 is particularly significant for regulating the availability of L-serine, which serves as a precursor for D-serine, a critical co-agonist for N-methyl-D-aspartate (NMDA) receptors involved in synaptic plasticity and memory (Foster et al., 2018). Mutations in the SLC1A4 gene are linked to a severe neurodevelopmental disorder known as spastic tetraplegia, thin corpus callosum, and progressive microcephaly (SPATCCM), highlighting its essential role in brain development (Srour et al., 2015). While no drugs are currently approved specifically to target ASCT1, L-serine supplementation is used to manage deficiency symptoms, and experimental small-molecule inhibitors like phenylglycine derivatives and alkoxy hydroxy-pyrrolidine carboxylic acids (AHPCs) are being investigated for their potential to modulate NMDA receptor activity in psychiatric and neurodegenerative conditions (Molecules 2024). Beyond the CNS, ASCT1 is expressed in peripheral tissues like the liver and pancreas, where it contributes to systemic amino acid balance and has been implicated in the progression of certain cancers such as hepatocellular carcinoma (Protein Atlas). The transporter also exhibits a thermodynamically uncoupled chloride conductance, which may influence cellular excitability and osmotic balance (Zerangue & Kavanaugh, 1996).

Other names
SLC1A4Alanine/serine/cysteine/threonine transporter 1SATTASCT-1Solute carrier family 1 member 4Neutral amino acid transporter A
02

Mechanism of action

Substrate replacement therapy (L-serine) and competitive inhibition of sodium-dependent neutral amino acid exchange.

03

Biological functions

Amino acid transportNeurotransmission regulationMetabolic homeostasisSerine shuttleChloride channel activity
04

Disease associations

Spastic tetraplegia, thin corpus callosum, and progressive microcephaly (SPATCCM)SchizophreniaNeurodegenerative diseaseHepatocellular carcinomaEpilepsy
05

Safety considerations

Off-target inhibition of ASCT2 (SLC1A5)Disruption of systemic amino acid homeostasisBlood-brain barrier penetration requirementsPotential for NMDA receptor over-activation or suppression
06

Interacting drugs

L-serine

4 more in the full profile.

07

Biomarkers

SLC1A4 gene mutationsL-serine levels in CSFD-serine levels in CSFMicrocephalyThin corpus callosum

Beyond the preview

Go deeper on Neutral amino acid transporter A (ASCT1) (ASCT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neutral amino acid transporter A (ASCT1) (ASCT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call